Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation
- 31 May 1992
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 31 (5) , 513-518
- https://doi.org/10.1016/0028-3908(92)90092-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted miceLife Sciences, 1990
- Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988
- Intrastriatal injection of dl-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapinePsychopharmacology, 1986
- Locomotor hypokinesia in the reserpine-treated rat: Drug effects from the corpus striatum and nucleus accumbensPharmacology Biochemistry and Behavior, 1982
- Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbensBrain Research, 1973